Outcomes of Adjunctive Therapy with Intravenous Cefoperazone-Sulbactam for Ventilator-Associated Pneumonia Due to Carbapenem-Resistant Acinetobacter baumannii.

Siripen KanchanasuwanNarongdet KositpantawongKamonnut SingkhamananThanaporn HortiwakulBoonsri CharoenmakNwabor Ozioma FYohei DoiSarunyou Chusri

Published in: Infection and drug resistance (2021)

Overall results suggested that patients with VAP due to CRAB strains who received adjunctive therapy with CEP-SUL had lower mortality rates and resource utilization compared with CEP-SUL-.

Keyphrases

acinetobacter baumannii
multidrug resistant
drug resistant
pseudomonas aeruginosa
cardiovascular events
risk factors
stem cells
cardiovascular disease
intensive care unit
low dose
mesenchymal stem cells
coronary artery disease
adipose tissue
smoking cessation